HHI Clinical Research Report issue

For profit Phase 2
Founded: Hunt Valley MD United States (2005)
Status: Acquired by inVentiv (2004) → now Syneos Health (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

fospropofol (lusedra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Polyps (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1